Main Article Content
Abstract
Background: Semarang is one of the cities in Central Java with the highest positive number and mortality rate of Covid-19. It became the largest contributor to daily cases in Central Java. In general, the severity of Covid-19 in Semarang is 5.3% and increased to 24% in the elderly. Mortality Covid-19 was caused by various factors such as demographic and non-demographic factors.
Objective: This study aims to determine the impact of several risk factors of COVID-19 mortality in Semarang.
Methods: This is an analytical cross-sectional study. Data analysis was carried out analytically with a binary logistic regression test. The sample used was the total population of 32.555 confirmed positive from March 2020 to March 2021 registered in Semarang Health Office.
Results: The results demonstrated that mortality due to Covid-19 in Semarang was frequent in the elderly (27.3%), males (9.4%), had comorbidities such as diabetes mellitus (28.6%), kidney disease (43.5%), neuromuscular (36.4%), and cancer (29.3%), and accompanied by symptoms such as Dyspnea (18.1%), weakness/lethargy (19.9%), and fever (14.6%).
Conclusion: Age, gender, travel history, comorbidities (kidney, neuromuscular, cancer, and diabetes mellitus), and symptoms (fever, shortness of breath, and weakness/lethargy) are risk factors for mortality Covid-19 in Semarang.
Keywords
Article Details
References
- Abdelhafiz AS, Mohammed Z, Ibrahim ME, Ziady HH, Alorabi M, Ayyad M, et al. Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19). J Community Health [Internet]. 2020;45(5):881–90. Available from: https://doi.org/10.1007/s10900-020-00827-7
- Mansuri FMA, Zalat MM, Khan AA, Alsaedi EQ, Ibrahim HM. Estimating the public response to mitigation measures and self-perceived behaviors towards the COVID-19 pandemic. J Taibah Univ Med Sci. 2020 Aug 1;15(4):278–83.
- Shi Y, Wang J, Yang Y, Wang Z, Wang G, Hashimoto K, et al. Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19. Brain, Behav Immun - Heal [Internet]. 2020;4(March):100064. Available from: https://doi.org/10.1016/j.bbih.2020.100064
- Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382(10):929–36.
- Covid-19. Peta Sebaran Covid-19. Gugus Tugas Percepatan Penanganan Covid-19 [Internet]. 2020;119:1–7. Available from: https://covid19.go.id/peta-sebaran
- Dinas Kesehatan Kota Semarang. Data Sebaran COVID-19 [Internet]. Available from: https://siagacorona.semarangkota.go.id/halaman/covid19
- Elimian KO, Ochu CL, Ebhodaghe B, Myles P, Crawford EE, Igumbor E, et al. Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: Retrospective cohort study. BMJ Open. 2020;10(12):1–16.
- Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon. 2020;6(12):1–24.
- Lu L, Zhong W, Bian Z, Li Z, Zhang K, Liang B, et al. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. J Infect. 2020;81(4):e18–25.
- Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8.
References
Abdelhafiz AS, Mohammed Z, Ibrahim ME, Ziady HH, Alorabi M, Ayyad M, et al. Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19). J Community Health [Internet]. 2020;45(5):881–90. Available from: https://doi.org/10.1007/s10900-020-00827-7
Mansuri FMA, Zalat MM, Khan AA, Alsaedi EQ, Ibrahim HM. Estimating the public response to mitigation measures and self-perceived behaviors towards the COVID-19 pandemic. J Taibah Univ Med Sci. 2020 Aug 1;15(4):278–83.
Shi Y, Wang J, Yang Y, Wang Z, Wang G, Hashimoto K, et al. Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19. Brain, Behav Immun - Heal [Internet]. 2020;4(March):100064. Available from: https://doi.org/10.1016/j.bbih.2020.100064
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382(10):929–36.
Covid-19. Peta Sebaran Covid-19. Gugus Tugas Percepatan Penanganan Covid-19 [Internet]. 2020;119:1–7. Available from: https://covid19.go.id/peta-sebaran
Dinas Kesehatan Kota Semarang. Data Sebaran COVID-19 [Internet]. Available from: https://siagacorona.semarangkota.go.id/halaman/covid19
Elimian KO, Ochu CL, Ebhodaghe B, Myles P, Crawford EE, Igumbor E, et al. Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: Retrospective cohort study. BMJ Open. 2020;10(12):1–16.
Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon. 2020;6(12):1–24.
Lu L, Zhong W, Bian Z, Li Z, Zhang K, Liang B, et al. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis. J Infect. 2020;81(4):e18–25.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8.